Not applicableUnknownNCT03958188What this trial is testingPreOPerative Imaging of NeuroEndocrine TumorsWho this might be right forNeuro-endocrine TumorsSmall Intestine Cancer Hospices Civils de Lyon 47
Not applicableActive Not RecruitingNCT03022188What this trial is testingNonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic IncidentalomaWho this might be right forNeuroendocrine Tumors Société Française d'Endoscopie Digestive 100
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Testing effectiveness (Phase 2)Ended earlyNCT01065805What this trial is testingDemonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or LymphomaWho this might be right forBrain CancerCancerSolid Tumor+1 more AHS Cancer Control Alberta 94
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT01469572What this trial is testingPasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic MetastasesWho this might be right forNeuroendocrine Tumors Emory University 13
Early research (Phase 1)Active Not RecruitingNCT05075993What this trial is testingStudy of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsWho this might be right forMetastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more M.D. Anderson Cancer Center 352
Very early researchActive Not RecruitingNCT03044977What this trial is testingStudy to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting David Bushnell 20
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT04478175What this trial is testingProspective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive OncologyWho this might be right forNon-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors Institut Curie 30
Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Very early researchUnknownNCT05961111What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid TumorsWho this might be right forSarcomaCarcinomaDigestive Cancer+7 more Shanghai Yunying Medical Technology 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291105What this trial is testingPhase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsWho this might be right forMelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer Vyriad, Inc. 87
Early research (Phase 1)Study completedNCT00375245What this trial is testingRapamycin With Grapefruit Juice for Advanced MalignanciesWho this might be right forTumorsNeoplasm Metastasis University of Chicago 41
Testing effectiveness (Phase 2)Study completedNCT02955069What this trial is testingStudy of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)Who this might be right forWell-differentiated Non-functional NET of Thoracic OriginWell-differentiated Non-functional NET of Gastrointestinal OriginWell-differentiated Non-functional NET of Pancreatic Origin+1 more Novartis Pharmaceuticals
Not applicableActive Not RecruitingNCT07817225What this trial is testingOptimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical EvaluationWho this might be right forPancreatic Neuroendocrine Tumor Massimo Falconi 30
Not applicableEnded earlyNCT02439008What this trial is testingEarly Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseWho this might be right forCarcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more Centre Oscar Lambret 28